Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- DIAG723Phase 21 trial
Diagonal Therapeutics, Inc. · Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension
- DII235Phase 21 trial
Novartis · Lipoprotein Disorder
- DiranersenISIS 814907, BIIB080Phase 21 trial
Biogen · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia
- DISC-3405Phase 21 trial
Disc Medicine, Inc · Polycythemia Vera (PV)
- Dispensing CodivirPhase 21 trial
Code Pharma · HIV, HIV Infection
- DJI136Phase 21 trial
Novartis · Extensive-stage Small Cell Lung Cancer (ES-SCLC)
- DKN-01LY2812176Phase 21 trial
Leap Therapeutics, Inc. · Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer
- DL001ZF2G22B, F2H23HPhase 21 trial
GSK · Influenza, Human
- DL001Z-NHF2H23D, F2H23BPhase 21 trial
GSK · Influenza, Human
- DM-101PXPhase 21 trial
Desentum Oy · Birch Pollen Allergy
- DM002Phase 21 trial
Xadcera Biopharmaceutical (Suzhou) Co., Ltd. · Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms
- DM005Phase 21 trial
Doma Biopharmaceutical(Suzhou)Co., Ltd. · Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of Head and Neck, Solid Carcinoma
- DNL126Phase 21 trial
Denali Therapeutics Inc. · Mucopolysaccharidosis Type IIIA
- DNL593Phase 21 trial
Denali Therapeutics Inc. · Frontotemporal Dementia
- DNL952Phase 21 trial
Denali Therapeutics Inc. · Late-onset Pompe Disease
- DNV001Phase 21 trial
Hangzhou Dinovate Biotech Co., Ltd · Primary Hypercholesterolemia
- DocetetaxelPhase 21 trial
Merck & Co. · Carcinoma, Non-Small-Cell Lung
- DONQ52Phase 21 trial
Chugai Pharmaceutical · Celiac Disease
- DR30206Phase 21 trial
Zhejiang Doer Biologics Co., Ltd. · Gastrointestinal Cancer
- DS-1103aPhase 21 trial
Daiichi Sankyo · Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
- DS-7011aPhase 21 trial
Daiichi Sankyo · Systemic Lupus Erythematosus
- DS3790aPhase 21 trial
Daiichi Sankyo · Hematological Malignancies, B-cell Non-Hodgkin Lymphoma
- DT-168Phase 21 trial
Design Therapeutics, Inc. · Fuchs Endothelial Corneal Dystrophy, Fuchs
- DT-216P2Phase 21 trial
Design Therapeutics, Inc. · Friedreich Ataxia
- DT-7012Phase 21 trial
Domain Therapeutics Australia Pty Ltd · Advanced Solid Tumors
- DusquetideSGX945, SGX942Phase 21 trial
Soligenix · Behçet Disease
- DWN12088DWN12088 XmgPhase 21 trial
Daewoong Pharmaceutical Co. LTD. · Idiopathic Pulmonary Fibrosis
- DX243Phase 21 trial
Dendrogenix · Age-related Hearing Loss
- DXC006Phase 21 trial
Hangzhou DAC Biotechnology Co., Ltd. · Small Cell Lung Cancer
- DYP688Phase 21 trial
Novartis · Metastatic Uveal Melanoma
- E2086Phase 21 trial
Eisai · Narcolepsy
- E2814Phase 21 trial
Eisai · Alzheimer's Disease
- E6742Phase 21 trial
Eisai · Systemic Lupus Erythematosus
- E7090Phase 21 trial
Eisai · Cholangiocarcinoma
- E7386Phase 21 trial
Eisai · Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular
- E7389-LFPhase 21 trial
Eisai · Solid Neoplasms
- EB-701CA9-NKPhase 21 trial
Beijing Biotech · Advanced or Metastatic Clear Cell Renal Cell Carcinoma
- EB06Phase 21 trial
Edesa Biotech Inc. · Non-Segmental Vitiligo (NSV)
- EB103Phase 21 trial
Estrella Immunopharma, Inc. · B-Cell Non-Hodgkin's Lymphoma (NHL), Lymphoma, Non-Hodgkins, Lymphomas Non-Hodgkin's B-Cell
- EC5026Phase 21 trial
EicOsis Human Health Inc. · Parkinson's Disease (PD)
- ECC0509Phase 21 trial
Eccogene · Metabolic Dysfunction-associated Steatohepatitis
- ECI830Phase 21 trial
Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
- EDG-15400Phase 21 trial
Edgewise Therapeutics, Inc. · Heart Failure With Preserved Ejection Fraction
- EDG-7500Phase 21 trial
Edgewise Therapeutics, Inc. · Hypertrophic Cardiomyopathy
- EDI048Phase 21 trial
Novartis · Cryptosporidiosis
- EDIT-401Phase 21 trial
Editas Medicine, Inc. · Heterozygous Familial Hypercholesterolemia (HeFH)
- EDP-938Phase 21 trial
Enanta Pharmaceuticals, Inc · RSV Infection
- EF-009Phase 21 trial
Everfront Biotech Co., Ltd. · Pancreatic Cancer
- EfesovirFS-1Phase 21 trial
Scientific Center for Anti-infectious Drugs, Kazakhstan · Covid19
- EfineptakinNT-I7, rhIL-7-hyFcPhase 21 trial
NeoImmuneTech · Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.